A detailed history of Fred Alger Management, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Fred Alger Management, LLC holds 166,014 shares of NRIX stock, worth $3.32 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
166,014
Previous 38,066 336.12%
Holding current value
$3.32 Million
Previous $794,000 369.4%
% of portfolio
0.02%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$18.93 - $25.69 $2.42 Million - $3.29 Million
127,948 Added 336.12%
166,014 $3.73 Million
Q2 2024

Aug 14, 2024

BUY
$12.02 - $21.3 $457,553 - $810,805
38,066 New
38,066 $794,000
Q2 2022

Aug 15, 2022

BUY
$7.88 - $14.82 $57,571 - $108,274
7,306 New
7,306 $93,000

Others Institutions Holding NRIX

About Nurix Therapeutics, Inc.


  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $942M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.